{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} What Obstetrician-Gynecologists Should Know About Substance Use Disorders in the Perinatal Period *6165*

Activity Steps

Description

Cognate Code 6165

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the prevalence of pregnancy-associated substance use and substance use disorder in the United States.
  2. Discuss the role of obstetrician-gynecologists in the identification and management of substance use disorder during pregnancy.
  3. Implement suitable strategies in your own practice to address these issues.
Price: $25.00

Credits:

  • ACOG 2.0 CME

The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College Cognate Credit(s) The American College of Obstetricians and Gynecologists designates this journal-based activity for a maximum of 2 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits TM to be equivalent to College Cognate Credits.

Professions: Physician
Test Code: ONG0222
Published: January 6, 2022
Expires: 2/28/2025
Required Passing Score: 7/10 (70%)
Authors: Marcela C. Smid, MD, MS, and Mishka Terplan, MD, MPH
Specialties: OB/GYN